David Thomson
General Counsel bei MANNKIND CORPORATION
Vermögen: 4 Mio $ am 31.05.2024
Aktive Positionen von David Thomson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MANNKIND CORPORATION | General Counsel | 01.01.2002 | - |
| Unternehmenssekretär | 01.01.2002 | - | |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - | - |
Karriereverlauf von David Thomson
Ausbildung von David Thomson
| Queen's University | Doctorate Degree |
| University of Toronto | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Kanada | 3 |
Operativ
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Secretary | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
- Börse
- Insiders
- David Thomson
- Erfahrung
